EROAD LIMITED (ERD)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

ERD

ERD - EROAD LIMITED

FNArena Sector : Transportation & Logistics
Year End: March
GICS Industry Group : Technology Hardware & Equipment
Debt/EBITDA: 0.54
Index: ALL-TECH

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.735

03 Mar
2026

-0.010

OPEN

$0.75

-1.34%

HIGH

$0.76

2,087,671

LOW

$0.73

OTHER COMPANIES IN THE SAME SECTOR
ACE . AIZ . AQZ . AVD . AZJ . BWN . BXB . CLX . FRW . KLS . KSC . LAU . NTD . QAN . QUB . SPZ . SST . THL . WTC .
FNARENA'S MARKET CONSENSUS FORECASTS

- No Record -

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2026 FactSet UK Limited. All rights reserved
Title 202020212022202320242025
EPS Basic xxxxxxxxxxxxxxx0.7
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx173.9 M
Book Value Per Share xxxxxxxxxxxxxxx161.2
Net Operating Cash Flow xxxxxxxxxxxxxxx39.3 M
Net Profit Margin xxxxxxxxxxxxxxx0.73 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202020212022202320242025
Return on Capital Employed xxxxxxxxxxxxxxx0.44 %
Return on Invested Capital xxxxxxxxxxxxxxx0.40 %
Return on Assets xxxxxxxxxxxxxxx0.31 %
Return on Equity xxxxxxxxxxxxxxx0.44 %
Return on Total Capital xxxxxxxxxxxxxxx1.27 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx27.1 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202020212022202320242025
Short-Term Debt xxxxxxxxxxxxxxx6 M
Long Term Debt xxxxxxxxxxxxxxx22 M
Total Debt xxxxxxxxxxxxxxx28 M
Goodwill - Gross xxxxxxxxxxxxxxx115 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx36 M
Price To Book Value xxxxxxxxxxxxxxx0.54

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202020212022202320242025
Capex xxxxxxxxxxxxxxx25.8 M
Capex % of Sales xxxxxxxxxxxxxxx14.82 %
Cost of Goods Sold xxxxxxxxxxxxxxx135 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx34 M
Research & Development xxxxxxxxxxxxxxx19 M
Investments - Total xxxxxxxxxxxxxxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

0
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

4

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Moelis

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Canaccord Genuity

xx/xx/xxxx

1

xxx

-

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Jarden

26/11/2025

4

Underweight

-

-

Jarden found few surprises in the first half result from Eroad, given recent market updates. The main positive was the free cash flow generation, although with the company reiterating FY26 revenue and free cash flow guidance it appears to be largely due to timing.

Eroad recently announced a rationalisation of the growth strategy in North America to focus on near-term opportunities in Australasia.

Opportunities in North America that were referenced earlier this year have been "deferred into later years", and the absence of historical pipeline conversion weighs on Jarden's confidence in a reacceleration in this market.

The earnings profile of the core business is downgraded and the target is lowered to NZ$1.55 from NZ$1.85. Underweight retained.

FORECAST
Jarden forecasts a full year FY26 EPS of minus -0.81 cents.
Jarden forecasts a full year FY27 EPS of 2.77 cents.

Shaw and Partners

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

ERD STOCK CHART